Results 101 to 110 of about 2,146 (159)

Switching from complement inhibitors in AQP4-IgG-positive NMOSD: clinical characteristics, an operational "cluster phase" and potential strategies to prevent therapeutic gaps. [PDF]

BMC Neurol
Sakurai K, Kaburagi K, Isahaya K, Akiyama H, Yamano Y.   +4 more
europepmc   +1 more source

Therapeutic advances in eculizumab for atypical hemolytic uremic syndrome: a narrative review. [PDF]

Front Pharmacol
Zhang D, Xiao Y, Ma H.
europepmc   +1 more source

Ravulizumab-Cwvz (Ultomiris®)

Oncology Times, 2019
openaire   +2 more sources

Epidemiology and care management of Paroxysmal Nocturnal Hemoglobinuria (PNH) in a real-world setting in France: Description from the French National Hospitalization Database. [PDF]

PLoS One
Peffault de Latour R, Pibre S, Vercruyssen J, Desjuzeur-Bellais ML, Pau D, Bénard S, Chillotti L, Grandfils N.   +7 more
europepmc   +1 more source

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial. [PDF]

Mult Scler
Bennett JL, Bhattacharyya S, Zabeti A, Levy M, de Sèze J, Taney MJ, Parks B, Allen K, Akpoji U, Pittock SJ.   +9 more
europepmc   +1 more source

Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage? [PDF]

BioDrugs
Arrivé C, Hotot M, Jourdil JF, Stanke-Labesque F.   +3 more
europepmc   +1 more source

Ravulizumab for paroxysmal nocturnal haemoglobinuria

, 2022
openaire   +1 more source

Complement C5 inhibition with eculizumab or ravulizumab is associated with increased cardiovascular and thromboembolic risk after ST-elevation myocardial infarction: a propensity-matched global retrospective cohort study. [PDF]

BMC Cardiovasc Disord
Vahldieck C.
europepmc   +1 more source

Comparative Efficacy of Complement Inhibitors in Complement Inhibitor-Naïve PNH: A Systematic Review With Supportive Exploratory Network Meta-Analysis of Randomized Trials. [PDF]

EJHaem
Ishaque R, Talpur AS, Sidra H, Memon H, Memon FT, Talat F, Rafiq T, Rayamajhi S.   +7 more
europepmc   +1 more source

Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany. [PDF]

Eur J Neurol
Gerischer L, Stein M, Schneider A, Tangen H, Loris J, Glaubitz S, Zschüntzsch J, Oy UH, Schubert C, Heesen C, Schlag M, Hagenacker T, Oeztuerk M, Ruck T, Doksani P, Dusemund C, Herdick M, Herzig-Nichtweiß J, Mergenthaler P, Stascheit F, Suboh A, Schwarz L, Hoffmann S, Meisel A, Lehnerer S.   +24 more
europepmc   +1 more source